quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 8, 2026

Tesla’s vote wasn’t about pay. It was about who really runs the company

View original at finance.yahoo.com
Tesla’s vote wasn’t about pay. It was about who really runs the company At Tesla’s 2025 Annual Meeting, something significant and important happened…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Tesla shareholders voted according to what they believed was in their financial interest and would create long-term value, exercising independent judgment rather than following proxy advisory firms

    80% confidence
  • Proxy advisory tools are increasingly misaligned with the realities of the modern economy and cannot meaningfully assess companies operating at the frontier of technological transformation

    80% confidence
  • Even excluding shares held by Elon Musk, the proposals passed by over 70%, well over the required majority threshold

    80% confidence
  • Shareholders have affirmed the substance of the 2018 CEO Performance Award on three separate occasions, each with support exceeding 75% of votes cast

    80% confidence
  • The days of blind deference to advisory firms that fail to appreciate the complexities of modern-day businesses are coming to an end

    80% confidence
  • The 2025 CEO Performance Award has no salary, no cash bonus, and no payout unless extraordinary milestones are reached

    80% confidence
  • Tesla's compensation plan is excessive and unconventional

    80% confidence
  • Tesla operates across artificial intelligence, robotics, autonomous solutions, energy systems, semiconductor development, and advanced manufacturing

    80% confidence
  • Derivative lawsuits are too often exploited as vehicles for opportunistic litigation, enriching plaintiff lawyers at the expense of shareholders

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Tesla’s vote wasn’t about pay. It was about who really runs the company — Source | Via News | pt.VIA.NEWS